A new class of balanced AT1/AT2 angiotensin II antagonists: quinazolinone AII antagonists with acylsulfonamide and sulfonylcarbamate acidic functionalities

[1]  W. Greenlee,et al.  Quinazolinones 1: design and synthesis of potent quinazolinone- containing AT1-selective angiotensin-II receptor antagonists , 1993 .

[2]  W. Greenlee,et al.  Quinazolinones 2: QSAR and in vivo characterization of AT1 selective AII antagonists , 1993 .

[3]  Y. Christen,et al.  Clinical experience with angiotensin II receptor antagonists. , 1992, American journal of hypertension.

[4]  J. Prost,et al.  Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. , 1992, Hypertension.

[5]  M. Entzeroth,et al.  Characterization of BIBS 39 and BIBS 222: two new nonpeptide angiotensin II receptor antagonists. , 1992, European journal of pharmacology.

[6]  J. Saavedra,et al.  Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing , 1992, Peptides.

[7]  R D Smith,et al.  Angiotensin II receptor subtypes. , 1992, American journal of hypertension.

[8]  D. Diz,et al.  Pharmacological characterization of angiotensin II binding sites in the canine pancreas , 1992, Peptides.

[9]  P. Timmermans,et al.  Losartan (DuP 753), An Orally Active Nonpeptide Angiotensin II Receptor Antagonist , 1991 .

[10]  R. Chang,et al.  Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonists. , 1991, Journal of medicinal chemistry.

[11]  R. Chang,et al.  Two angiotensin II binding sites in rat brain revealed using [125I]Sar1, Ile8-angiotensin II and selective nonpeptide antagonists. , 1990, Biochemical and biophysical research communications.

[12]  S. Whitebread,et al.  Preliminary biochemical characterization of two angiotensin II receptor subtypes. , 1989, Biochemical and biophysical research communications.